CardioExchange Archive

December 15th, 2014

The Latest on Culprit-Vessel vs. Multivessel Primary PCI for STEMI

Bilal Iqbal, MBBS MRCP PhD and CardioExchange Editors, Staff

We interview Bilal Iqbal about his real-world observational analysis of culprit-vessel vs. multivessel intervention at the time of primary PCI for STEMI.

---

October 17th, 2013

New Insights Into Surgery vs. Stents for Diabetics with Multivessel Disease

Larry Husten, PHD

Last year the large NHLBI FREEDOM trial demonstrated that coronary-artery bypass graft (CABG) surgery was superior to PCI when treating diabetic patients who have multivessel coronary disease. CABG resulted in significant reductions in death and MI, but this was offset slightly by a higher rate of stroke in the CABG group. Now, a new report from FREEDOM […]

---

August 5th, 2013

Poll: What Would You Recommend?

Richard A. Lange, MD, MBA

Take the poll: What would you recommend for a patient who is about to undergo CABG for multivessel CAD and is found to have severe carotid stenosis?

---

January 2nd, 2013

CABG Highly Cost-Effective in Diabetics with Multivessel Disease

Larry Husten, PHD

In November the main results of the FREEDOM trial showed that diabetics with multivessel disease do better with CABG than PCI. Now the findings of the trial’s cost-effectiveness study, published online in Circulation, demonstrate that CABG is also highly cost-effective when compared with PCI. Elizabeth Magnuson and colleagues  found that although CABG initially cost nearly $9000 more than PCI ($34,467 […]

---

November 4th, 2012

FREEDOM Lends Strong Support to CABG for Diabetics with Multivessel Disease

Larry Husten, PHD

CABG is associated with better cardiovascular outcomes than PCI in patients with diabetes and multivessel disease.

---